Skip to content
Stop using now Drug recall · FDA · Published December 12, 2013

Hospira Recalls Propofol Vials Due to Glass Particulate Hazard

Hospira Inc. recalls Propofol Injectable Emulsion vials due to glass particulate matter that could dislodge into the solution.

🇺🇸 FDA recall #D-1033-2014DrugHospira ›
Take action

Contact the company

Recalling firmHospira Inc.275 N Field Dr · Lake Forest, IL 60045-2579
✎ GovInfoNow plain-language explainer

Hospira Inc. is recalling Propofol Injectable Emulsion, 1%, 200 mg/20 mL single patient infusion vials because of a manufacturing defect in the glass vial neck. This defect can cause small glass flakes or embedded metal particulate to become dislodged into the medication solution. The recall affects 126,425 vials distributed nationwide. Read more at govinfonow.com/recall/46361-hospira-inc-recalls-propofol-injectible-emulsion-1-200-mg-20.

Source Summary by GovInfoNow · govinfonow.com/recall/46361-hospira-inc-recalls-propofol-injectible-emulsion-1-200-mg-20 · Updated October 13, 2026 · FDA enforcement record: FDA #D-1033-2014

Cite this page

“Hospira Recalls Propofol Vials Due to Glass Particulate Hazard.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46361-hospira-inc-recalls-propofol-injectible-emulsion-1-200-mg-20. Based on FDA recall #D-1033-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1033-2014%22&limit=1).

The FDA announced on 2013-12-12 that Hospira Inc. is recalling Propofol Injectable Emulsion Vials due to the presence of particulate matter, specifically glass flakes or metal particles, according to GovInfoNow's records. The recall affects 126,425 vials distributed nationwide.

How to tell if you have it

  • Brand: Hospira
  • Product: Propofol Injectable Emulsion Vials
  • NDC: 0409-4699-30
  • Lot #: 27-568-DJ* (may be followed by 01)
  • Expiration: 03/15
  • Quantity: 126,425 vials

The hazard

The hazard involves the presence of particulate matter caused by a glass defect on the interior neck of the vial. This defect can result in small glass flakes or embedded metal particulate becoming dislodged into the solution.

Context

GovInfoNow's records show Hospira Inc. has 108 other recalls on record since 2012-04-05. Other recent recalls of similar products include American Regent Papaverine HCl Injection Recall (2026-07-24), Liebel-Flarsheim Optiray Imaging Bulk Package-350 Recall (2026-07-31), and Sun Pharmaceutical DOXOrubin Liposome Injection Recall (2026-05-12).

How to tell if you have this one

Check for Propofol Injectable Emulsion, 1%, 200 mg/20 mL (10 mg/mL), 20 mL Single patient infusion vials packaged in 5 Units x 20. Look for NDC 0409-4699-30 and Lot # 27-568-DJ* (where * may be followed by 01) with an expiration date of 03/15.

  • Brand
    Hospira
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop using the affected vials

    Do not use any Propofol Injectable Emulsion vials matching the recalled lot numbers due to the risk of particulate contamination.

  2. Contact Hospira Inc for details

    Reach out to the manufacturer for further instructions on handling or returning the product, as specific remedy steps are not detailed in this record.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 10 months after the firm started it.

1. Firm started the recall: Dec 12, 201312. FDA classified it Class II: Jan 23, 201423. Published in FDA’s Enforcement Report: Jan 29, 201434. FDA terminated the recall: Oct 16, 2014420132014
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-1033-2014 (December 12, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1033-2014 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA